======= PLA2G2E ======= == Gene Information == * **Official Symbol**: PLA2G2E * **Official Name**: phospholipase A2 group IIE * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=30814|30814]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZK7|Q9NZK7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLA2G2E&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLA2G2E|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618320|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: PA2 catalyzes the calcium-dependent hydrolysis of the 2- acyl groups in 3-sn-phosphoglycerides. Has a preference for arachidonic-containing phospholipids. |Phospholip A2 1| |low-density lipoprotein particle remodeling| |calcium-dependent phospholipase A2 activity| |phosphatidylinositol acyl-chain remodeling| |phosphatidylglycerol acyl-chain remodeling| |phosphatidylserine acyl-chain remodeling| |arachidonate transport| |arachidonic acid secretion| |phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine)| |phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine)| |phosphatidylethanolamine acyl-chain remodeling| |phosphatidylcholine acyl-chain remodeling| |icosanoid secretion| |phospholipase A2 activity| |plasma lipoprotein particle remodeling| |protein-lipid complex remodeling| |protein-containing complex remodeling| |phosphatidylglycerol metabolic process| |fatty acid derivative transport| |icosanoid transport| |phosphatidylserine metabolic process| |phosphatidic acid biosynthetic process| |phosphatidic acid metabolic process| |plasma lipoprotein particle organization| |protein-lipid complex subunit organization| |long-chain fatty acid transport| |regulation of plasma lipoprotein particle levels| |fatty acid transport| |phosphatidylcholine metabolic process| |acid secretion| |phospholipid binding| |monocarboxylic acid transport| |phosphatidylinositol metabolic process| |ammonium ion metabolic process| |cellular modified amino acid metabolic process| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |phospholipid biosynthetic process| |carboxylic acid transport| |organic acid transport| |lipid transport| |lipid catabolic process| |glycerophospholipid metabolic process| |lipid localization| |phospholipid metabolic process| |glycerolipid metabolic process| |extracellular structure organization| |organic anion transport| |inflammatory response| |organophosphate biosynthetic process| |lipid biosynthetic process| |anion transport| |calcium ion binding| |organophosphate metabolic process| |cellular lipid metabolic process| |secretion| |lipid metabolic process| |defense response| |ion transport| |organic substance catabolic process| |protein-containing complex subunit organization| |extracellular region| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp326|CCT251545 20μM R07 exp326]]|1.73| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|1.87| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.02| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 13094 * **Expression level (log2 read counts)**: -6.6 {{:chemogenomics:nalm6 dist.png?nolink |}}